Checkmate Pharmaceuticals
ID: 5329461Checkmate Pharmaceuticals is a Cambridge, Massachusetts-based biopharmaceutical company focused on the activation of the innate immune system to treat cancer. The company was acquired by Regeneron in May 2022.
5
Funding Rounds
$229.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Pe*** Co******* | - | - | linkedin twitter instagram |
Funding
Funding series
Funding Series Analysis
The company Checkmate Pharmaceuticals has raised a total of $107m in funding over 5 rounds.
Key Insights:
- Checkmate Pharmaceuticals Series C round, June 2020: $85m
- Checkmate Pharmaceuticals , December 2018: $22m
- Checkmate Pharmaceuticals Series B round, June 2017: $27m
- Checkmate Pharmaceuticals, Inc. funding round, April 2020: $10m
- Checkmate Pharmaceuticals, Inc. Series C round, June 2020: $85m
Industries
Checkmate Pharmaceuticals is active in the following industries: